← All trials
NCT01744587
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2013
- Primary completion
- Dec 1, 2020
- Completion date
- Dec 1, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 352
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Government of TaiwanLead sponsor
- Taichung Veterans General HospitalOverall official - principal investigator
- Taiwan Cooperative Oncology GroupStudy director
- Taichung Veterans General HospitalCollaborator
- National Taiwan UniversityCollaborator
- Mackay Medical CollegeCollaborator
- Chang Gung UniversityCollaborator
- National Cheng Kung UniversityCollaborator
- China Medical UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.